Study identifier:NIS-OBG-XXX-2012/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A Retrospective Cohort Study on Therapeutic Management of Metastatic Breast Cancer in Clinical Practice in Bulgaria
Metastatic Breast Cancer
N/A
No
-
Female
171
Observational
18 Years - 150 Years
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jun 2014 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
Female patients diagnosed with metastatic breast cancer Patients newly diagnosed with metastatic breast cancer, either De Novo or having progressed from a non-metastatic stage. | - |